Status:
COMPLETED
JETi Lower Extremity Arterial Thrombosis
Lead Sponsor:
Abbott Medical Devices
Conditions:
Arterial Thrombosis
Eligibility:
All Genders
18+ years
Brief Summary
The JETi Registry is a prospective, single-arm, multi-center study to collect real-world data on the safety, performance, and clinical benefits of the JETi™ Hydrodynamic Thrombectomy System (JETi Syst...
Eligibility Criteria
Inclusion
- Subject was treated or is expected to be treated for acute/subacute thrombosis, as determined by the investigator, in the peripheral vasculature with the JETi Hydrodynamic Thrombectomy System.
- Subject or legally authorized representative must provide written informed consent.
- Subject must be ≥ 18 years of age
Exclusion
- Subject has previously been registered in the JETi Registry in the last 12 months unless treated in the contralateral limb/different anatomy; patients treated in the contralateral limb/different anatomy within the last 12 months may re-enroll in the study.
- Subject is currently participating in another drug or device clinical investigation.
- Subject has active symptoms and/or a positive test result of COVID-19 or other rapidly spreading novel infectious agent within the past 20 days.
Key Trial Info
Start Date :
March 6 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 9 2024
Estimated Enrollment :
129 Patients enrolled
Trial Details
Trial ID
NCT04370691
Start Date
March 6 2020
End Date
October 9 2024
Last Update
June 17 2025
Active Locations (30)
Enter a location and click search to find clinical trials sorted by distance.
1
Honor Health
Scottsdale, Arizona, United States, 85258
2
Arkansas Heart
Little Rock, Arkansas, United States, 72211
3
PIH Good Samaritan
Los Angeles, California, United States, 90017
4
Cedars Sinai Medical Center
Los Angeles, California, United States, 90095